Arquitos Capital’s Steven Kiel joined Robert Kraft’s The Investors Roundtable to discuss COVID-19 vaccine trial results and investing in healthcare.
Steven Kiel Participates in The Investors Roundtable #21
Previous
Previous
Willow Oak Releases Episode 9 of Value Hour
Next
Next